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Many human diseases are associated with protein aggregation and fibrillation. Using glucagon as
a model system for protein fibrillation we show that fibrils grow in an intermittent fashion, with
periods of growth followed by long pauses. Remarkably, even if the intrinsic transition rates vary
considerably in each experiment, the probability of being in the growing (stopping) state is very
close to 1/4 (3/4), suggesting the presence of 4 independent conformations of the fibril tip. We
discuss this possibility in terms of existing structural knowledge.
Protein fibrillation is the process by which misfolded
proteins tend to form large linear aggregates [1]. Its im-
portance is related to the role played in many degenera-
tive diseases, such as Parkinson’s, Alzheimer’s, Hunting-
ton and prion diseases [2]. While our knowledge of the
structural properties of these fibrils improves at great
pace [3, 4], the dynamics of their growth process is still
poorly understood. The formation of amyloid fibrils in-
volves at least two steps: the formation of growth centers
by primary nucleation, which is often a slow process, fol-
lowed by elongation through addition of monomers [5].
In many cases, a so-called secondary nucleation mech-
anism is also involved, whereby new growth centers are
formed from existing fibrils [6, 8, 9]. Whereas the process
of secondary nucleation is known to entail a number of
different mechanisms [9, 10], the primary elongation pro-
cess has not been elucidated to the same level of detail.
In this communication, we present an experimental
and theoretical study of the elongation process of glu-
cacon fibrils. Glucagon is a small peptide hormone con-
sisting of only 29 amino acids produced in the pancreas.
It has the opposite effect to that of insulin and therefore
increases blood glucose levels when released. As a model
system for protein fibrillation, glucagon kinetics has pro-
vided insights into the early oligomerization stages of the
process [11–13], the interplay between growth and fibril
morphology [14, 15] and amyloid branching [9]. Here,
we focus on the properties of the late-stage elongation
process.
Experiments were performed on samples of glucagon
monomers in solution. In order to detect the growth,
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a specialized fluorescence microscopy technique was ap-
plied, the so-called Total Internal Reflection Fluorescence
Microscopy (TIRFM) (Supplementary method). The
TIRFM images of the fibrillation process were obtained
at initial glucagon concentration of ρ = 0.25 mg/ml in
aqueous buffer (50 mM glycine HCl pH 2.5) with pre-
formed seeds. Images of the growth are shown in Fig. 1
at three consecutive times t = 0, 216 , 407 min.
Because the fibrils grow along the glass slide we are
able to track each fibril length as function of time. We
monitor 16 independent fibrils for each image frame in
the experiment. The time interval, Δt, between frames
varies from a minimum value of Δtmin = 1 min. to a
maximum value Δtmax = 35 min., with a typical value
of Δt = 10 min.. The total duration of the experiment
is t = 525 min. The combined results for the 16 fibrils
are shown in Fig. 2.
A striking feature of the fibril dynamics is its discrete
nature, where long periods of growth are interrupted by
extended periods of stasis (stop state). This prompted
us to collect the statistics of time spent in the growth
(g) and the stop (s) state, fg(t) and fs(t) respectively,
for all 16 fibrils. In Fig. 3, these distributions are shown
on semi-logarithmic plots. Note that the finite sampling
rate implies that actual time spent in given state can only
be estimated in terms of upper and lower bounds (Sup-
plementary Methods). The upper estimates are shown
by the dashed blue curves and the lower estimates are
shown by the full blue curves. As seen in the figure, the
difference between the distributions for the upper and
lower estimates of both fg and fs are marginal. All dis-
tributions are very well fitted by exponential functions,
fg(t) ∼ exp(−k−t) and fs(t) ∼ exp(−k+t), as shown
by the yellow curves (here, the dashed yellow curve is
the fit to the upper estimates and the full yellow curve
2t = 216 min.
t = 409 min.
t = 0 min.
FIG. 1: TIRFM images of glucacon fibril growth with initial
glucagon concentration of ρ = 0.25 mg/ml in aqueous buffer
(50 mM glycine HCl pH 2.5) at three consecutive times after
the initiation of the aggregation. Red lines in the last picture
mark examples of fibrils which are tracked during the growth
process.
is the fit of the lower estimates). The fits are of ex-
cellent quality over almost two decades, as signified by
high R values (R2 > 0.98). The values obtained are
k+ = 9.0 · 10−3 min−1 and k− = 2.8 · 10−2 min−1.
A series of four independent experiments have been per-
formed with the same glucagon monomer concentration
(0.25 mg/ml) and pH (2.5) with differences in the seed
concentrations (∼20% variation) and data acquisition
only (Supplementary Table 1). In all four cases the same
analysis and procedure was performed resulting in expo-
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FIG. 2: Length as a function of time for 16 fibrils tracked
from the images shown in Fig 1. Note the long plateaus, cor-
responding to the stop states, followed by shorter (on average)
growing periods. The average growth is indicated with a dot-
ted blue line. The sampling time between each image can be
seen from the time separation between each point.
nential distributions of similar high quality.
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FIG. 3: Growth fg(t) (a) and stop fs(t) (b) times distribu-
tions on semi-logarithmic scales. Blue lines are data and yel-
low straight lines are the exponential fit. Both for data and
fits, continuous lines are the lower estimates and dashed lines
are the upper estimates (see text). All fits are of extremely
good quality as indicated by the large R-value, R2 > 0.98.
The observed stop and go behaviour of fibril dynam-
ics is clearly not associated with the discrete nature of
monomer attachment (Supplementary Methods). The
simplest model of the process is to assume that the fib-
ril exhibits two internal states: one in which it is al-
lowed to grow, with a rate g and one in which it cannot
3grow (Supplementary Figure 1). Consistent with data,
the time spent in each state would be exponentially dis-
tributed and the transition rates between the two states
can therefore be identified with the observed rates k+
(stop→ growth) and k− (growth → stop). Denoting the
total rate k = k+ + k−, one can calculate the proba-
bility of being in the growing state, p+ = k+/k and in
the stopped state, p− = k−/k. By comparing the re-
sults from 4 independent experiments we observe that
the rates k+ and k− vary quite significantly, up to a fac-
tor 3 (Supplementary Table 1). A possible explanation
for this could be the variation in sampling frequency, due
to heating of the sample by the laser. Indeed, the depen-
dency of the fibril growth on both the laser intensity as
well as the illumination time has been observed under
similar experimental conditions for β2-microglobulin ki-
netics [16].
The striking result is that, even though both transition
rates vary among experiments, they combine in such a
way that the probabilities of growing and stopping, p+
and p−, do not change appreciably in different experi-
ments (Supplementary Table 1). In particular, p+ is al-
ways very close to 1/4 and consequently p− is very close
to 3/4. Notice that, if the difference between the growing
and the stopped state would have been due to an energy
gap, one would have expected the population ratio of
the two states to be much more sensitive to variations in
the individual transition rates, k±. Conversely, the con-
stancy of this ratio suggests that the energy difference
between the growing and the stopped states to be irrele-
vant. This ratio could then reflect the presence of three
stopped configurations for each growing one, all of them
being iso-energetic.
Recently, similar stop-and-go behavior of the fibril
elongation of Aβ -peptides [17, 18] and α-synuclein [19]
have been reported although the timescales involved are
1-2 orders of magnitude faster. This suggests that the
observed kinetics reflects the presence of some kind of
structural change at the fibril ends, which is not neces-
sarily specific to glucagon. In this picture, the protein
properties would affect the barrier height, and thus the
timescale of the process, only.
If our hypothesis about the existence of approximately
isoenergetic states holds up to scrutiny, it suggests that
there may be an additional dimension in the fibrillation
energy landscape that cannot easily be identified by con-
ventional techniques. Glucagon is known to adopt a num-
ber of different conformations depending on the fibrilla-
tion conditions, but these conformations differ consider-
ably in energy and are unlikely to co-exist to an equal
extent [20] . Rather, it is possible that we have a num-
ber of closely related states with different propagation
properties which are separated by high local activation
barriers within a relatively flat ground state level. Fur-
ther experimental studies are required to establish the
validity of our scenario.
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